Platform Nanotechnologies for Oral Delivery of Drugs, Therapeutic Protein and Peptide Delivery
Platform Nanotechnologies for Oral Delivery of Drugs, Therapeutic Protein and Peptide Delivery
用于口服药物、治疗性蛋白质和肽递送的纳米技术平台
批准号：
nhmrc : GNT1146627
负责人：
Dr Amirali Popat
金额：
$43.1万
依托单位国家：
澳大利亚
项目类别：
Career Development Fellowships
财政年份：
2018
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2018-01-01 至 --
中文摘要
翻译
为问题药物和生物制剂开发可靠的口服给药系统是近年来制药行业面临的最大挑战之一。为了应对这些挑战，我开发了可编程纳米颗粒，能够有效地口服多种药物，包括大肽和蛋白质。
英文摘要
The development of reliable oral delivery systems for problem drugs and biologics is one of the biggest challenges faced by the pharmaceutical industry in recent times. In order to tackle these challenges, I have developed programmable nanoparticles capable of efficiently deliver wide range of drugs including large peptides and proteins orally.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE): Quality and safety in the implementation of medicinal cannabis use in the community
-
批准号：nhmrc : GNT1135054
-
项目类别：Centres of Research Excellence
-
资助金额：$249.85万
-
财政年份：2017
-
负责人：Dr Amirali Popat
-
依托单位：
HDAC3 as a novel orchestrator of lipid oxidation in the intestine and potential therapeutic target in obesity.
-
批准号：nhmrc : GNT1107836
-
项目类别：Project Grants
-
资助金额：$52.64万
-
财政年份：2016
-
负责人：Dr Amirali Popat
-
依托单位：
海外基金
